These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

200 related items for PubMed ID: 7454626

  • 1. Toxicological studies on the new veterinary antibiotic turimycin.
    Härtl A, Hoffmann H.
    Pol J Pharmacol Pharm; 1980; 32(2):217-24. PubMed ID: 7454626
    [Abstract] [Full Text] [Related]

  • 2. [Pharmacological and toxicological study of turimycin].
    Härtl A, Kirchner E, Horn U, Stöckel U, Güttner J, Hoffmann H.
    Arch Exp Veterinarmed; 1979 Jan; 33(1):111-9. PubMed ID: 454085
    [Abstract] [Full Text] [Related]

  • 3. Pharmacokinetic characteristics of the new veterinary antibiotic turimycin.
    Hoffmann H, Härtl A.
    Pol J Pharmacol Pharm; 1980 Jan; 32(2):211-6. PubMed ID: 7454625
    [Abstract] [Full Text] [Related]

  • 4. General pharmacology of the new antimuscarinic compound vamicamide.
    Yamamoto T, Honbo T, Tokoro K, Kojimoto Y, Kodama R, Ohtsuka M, Shimomura K.
    Arzneimittelforschung; 1995 Dec; 45(12):1274-84. PubMed ID: 8595084
    [Abstract] [Full Text] [Related]

  • 5. Sulfonyliminoimidazolidines, a new class of oral hypoglycemic agents. 4. Toxicity and general pharmacology of 1-[p-[2-(crotonylamino)-ethyl]-phenylsulfonyl]-3-cyclohexy l-2-imino- imidazolidine (CGP 11 112).
    Märki F, Büch O, Delini-Stula A, Kraetz J, Petermann H, Radeke E, Schweizer A, Thomann P, Truog A.
    Arzneimittelforschung; 1984 Dec; 34(3):247-52. PubMed ID: 6539603
    [Abstract] [Full Text] [Related]

  • 6. Toxicological studies on a new veterinary antibiotic turimycin.
    Härtl A, Horn U, Kirchner E, Güttner J, Hoffmann H.
    Arch Toxicol Suppl; 1978 Dec; (1):235-7. PubMed ID: 277107
    [Abstract] [Full Text] [Related]

  • 7. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program .
    Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
    [Abstract] [Full Text] [Related]

  • 8. General pharmacological profile of the new cognition-enhancing agent nefiracetam.
    Kitano Y, Makino M, Usui C, Takasuna K, Kasai Y, Hirohashi M, Tamura K, Takayama S, Kojima H, Iizuka H.
    Arzneimittelforschung; 1994 Feb; 44(2A):199-210. PubMed ID: 8018090
    [Abstract] [Full Text] [Related]

  • 9. General pharmacology of recombinant human basic fibroblast growth factor.
    Okumura M, Yajima M, Nishimura T, Ikeda H, Nishimori T.
    Arzneimittelforschung; 1996 Jul; 46(7):727-39. PubMed ID: 8842346
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Pharmacological studies on the venomous spotted butterfish (Scatophagus argus Linn) sting extract on experimental animals.
    Muhuri D, Karmakar S, Dasgupta SC, Nagchaudhuri AK, Gomes A.
    Indian J Exp Biol; 2004 May; 42(5):461-7. PubMed ID: 15233469
    [Abstract] [Full Text] [Related]

  • 13. [Pharmacologic, toxicologic study of turimycin (proceedings)].
    Härtl A, Kirchner E, Horn U, Güttner J, Hoffmann H.
    Pharmazie; 1979 May; 34(5-6):340-1. PubMed ID: 515148
    [No Abstract] [Full Text] [Related]

  • 14. Pharmacological and toxicological properties of ryodipine.
    Kimenis AA, Vitolina RO, Petersone IO, Germane SK, Briede JL.
    Arzneimittelforschung; 1985 May; 35(4):672-9. PubMed ID: 4015733
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Pharmacology of secoverine, a new spasmolytic agent with specific antimuscarinic properties. Part 2: General pharmacological properties.
    Zwagemakers JM, Claassen V.
    Arzneimittelforschung; 1980 May; 30(9):1526-34. PubMed ID: 7193021
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. General pharmacological profile of the new anti-ulcer drug 3-[[[2-(3,4-dimethoxyphenyl)ethyl]carbamoyl]methyl]-amino-N -methylbenzamide.
    Hirohashi M, Takasuna K, Kasai Y, Usui C, Tamura K, Kojima H.
    Arzneimittelforschung; 1993 May; 43(5):569-77. PubMed ID: 8329002
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.